InnoCare Pharma and KeyMed Biosciences announced that they, along with their joint venture, have collectively signed an exclusive licensing agreement with Prolium Bioscience (Prolium) for the advancement and marketing of ICP-B02 (CM355)...
GSK plc announced that the European Commission has authorized Jemperli (dostarlimab) in conjunction with chemotherapy (carboplatin and paclitaxel) as a first-line therapy for adult patients with primary advanced or recurrent endometrial cancer...
SCHOTT Pharma, a leader in drug containment and delivery solutions, introduces the next generation of SCHOTT TOPPAC infuse polymer syringes, a system aimed at enhancing safety, efficiency, and sustainability in the healthcare sector. Created in...
Indian pharmaceutical experts anticipate positive trade conditions with Donald Trump assuming the presidency of the US. The United States continues to be an important market for Indian pharmaceutical firms, representing roughly 30% of India's...
Strides Pharma Science Limited has announced that its wholly owned subsidiary, Strides Pharma Global Pte Limited, Singapore, has obtained approval from the United States Food & Drug Administration (USFDA) for Acetaminophen and Ibuprofen Tablets...
Amgen announced that the US Food and Drug Administration (FDA) has granted approval for Lumakras (sotorasib) in conjunction with Vectibix (panitumumab) for treating adult patients with KRAS G12C-mutated metastatic colorectal cancer (mCRC)...
Guangzhou Fermion Technology Co., Ltd., an AI-focused biotech firm in clinical development, and Simcere Pharmaceutical Group Limited, a pharmaceutical entity, have announced a collaboration to advance a clinical-stage pain treatment asset, FZ002...
AstraZeneca's Calquence (acalabrutinib), combined with bendamustine and rituximab, has received approval in the US for treating adult patients with previously untreated mantle cell lymphoma (MCL) who cannot undergo autologous hematopoietic stem...
Indian pharmaceutical company Zydus has been granted approval by the USFDA to perform a Phase II(b) clinical trial aimed at identifying the ideal dosage strength of Usnoflast, an innovative oral NLRP3 inflammasome inhibitor for individuals with...
Caris Life Sciences (Caris), a prominent next-generation AI TechBio firm and a leader in precision medicine, revealed a strategic and multifaceted partnership with Ontada, a company focused on oncology real-world evidence, clinical education, and...
, CDSCO.jpg)
